N. Akbari and M. Saadat, “No Evidence for an Association Between the Chemokine Receptor 5 Δ32 Polymorphism and Multiple Sclerosis Susceptibility: A Meta-Analysis: CCR5-Δ32 and MS, meta-analysis ”, Scr Med, vol. 56, no. 1, pp. 105–115, Feb. 2025, doi: 10.5937/scriptamed56-54562.